drugset / Trial / NCT07230600

AD-SVF Therapy for Refractory Endometrial Infertility

NCT07230600 ↗

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to initially explore the efficacy of adipose-derived stromal vascular fraction (AD-SVF) therapy in the treatment of refractory endometrial infertility.

Timeline

Start
2025-11
Primary completion
2026-12
Completion
2027-06

Drugs

EvaluationDrugModalityDoseRoute
Subject AD-SVF Cell therapy — Other

Indications